Human Phospho-Chk2 (T68) Antibody
R&D Systems, part of Bio-Techne | Catalog # AF1626
Key Product Details
Validated by
Biological Validation
Species Reactivity
Validated:
Human
Cited:
Human
Applications
Validated:
Immunocytochemistry, Western Blot
Cited:
Immunocytochemistry, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Product Specifications
Immunogen
Phosphopeptide containing human Chk2 T68 site
Specificity
Detects human Chk2 when phosphorylated at T68.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Human Phospho-Chk2 (T68) Antibody
Detection of Human Phospho-Chk2 (T68) by Western Blot.
Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line untreated (-) or treated (+) with 1 µM camptothecin (CPT) for 1 hour. PVDF membrane was probed with 0.5 µg/mL Rabbit Anti-Human Phospho-Chk2 (T68) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1626) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). A specific band for Phospho-Chk2 (T68) was detected at approximately 64 kDa (as indicated). The phospho-specificity of this antibody was supported by decreased labeling following treatment with 600 U lambda-phosphatase (lambda-PPase) for 60 minutes. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.Phospho-Chk2 (T68) in HepG2 Human Cell Line.
Phopsho-Chk2 (T68) was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line treated with 1 µM camptothecin using Rabbit Anti-Human Phospho-Chk2 (T68) Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1626) at 1 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rabbit IgG Secondary Antibody (red; Catalog # NL004) and counterstained with DAPI (blue). Specific staining was localized to nuclei in treated cells. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.Applications for Human Phospho-Chk2 (T68) Antibody
Application
Recommended Usage
Immunocytochemistry
5-15 µg/mL
Sample: Immersion fixed HeLa human cervical epithelial carcinoma cell line treated with camptothecin, immersion fixed HepG2 human hepatocellular carcinoma cell line treated with camptothecin, and immersion fixed equine peripheral blood mononuclear cells (PBMCs) treated with calcium ionomycin and PMA
Sample: Immersion fixed HeLa human cervical epithelial carcinoma cell line treated with camptothecin, immersion fixed HepG2 human hepatocellular carcinoma cell line treated with camptothecin, and immersion fixed equine peripheral blood mononuclear cells (PBMCs) treated with calcium ionomycin and PMA
Western Blot
0.5 µg/mL
Sample: HeLa human cervical epithelial carcinoma cell line treated with camptothecin
Sample: HeLa human cervical epithelial carcinoma cell line treated with camptothecin
Reviewed Applications
Read 2 reviews rated 4.5 using AF1626 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Chk2
Long Name
Checkpoint Kinase 2
Alternate Names
CDS1, CHEK2, HuCds1, LFS2, PP1425, Rad53
Gene Symbol
CHEK2
Additional Chk2 Products
Product Documents for Human Phospho-Chk2 (T68) Antibody
Product Specific Notices for Human Phospho-Chk2 (T68) Antibody
For research use only
Loading...
Loading...
Loading...
Loading...